Hypertension and diabetes

PCOS is associated with a three to seven times increased risk of developing type 2 diabetes.14 Patients diagnosed with PCOS should be screened for impaired glucose tolerance, diabetes, hypertension, and dyslipidemia.12 If any of these conditions are present, there is an increased risk of cardiovascular events. 

A 72-year-old man with a history of congestive heart failure, diabetes, hypertension, and hyperlipidemia presents to the local emergency room with complaints of increasing shortness of breath, cough productive of yellow-green sputum, chest pain, fever, and malaise. He was hospitalized 12 days ago for urosepsis, for which he received 1 0 days of levofloxacin. 

Disease risk for type 2 diabetes, hypertension, and cardiovascular disease. 

Phenylephrine is a nasal decongestant that mimics the sympathetic system, thereby increasing the heart rate and blood pressure. It may aggravate conditions such as diabetes, hypertension and glaucoma. Patients with hypertension, ischaemic heart disease, hyperthyroidism, diabetes and glaucoma are therefore given topical nasal sympathomimetics rather than systemic sympathomimetics. Both topical and systemic sympathomimetics are contraindicated in patients taking monoamine oxidase inhibitors, because concurrent administration of the two products may lead to a hypertensive crisis. 

A 62-year-old woman with type 2 diabetes, hypertension, and chronic hepatitis C virus infection developed palpable purpura over her legs and buttocks 3 weeks after starting to take repaglinide 500 mg qds (52). The purpura ulcerated and became infected. Repaglinide was withdrawn and the purpura resolved. A biopsy showed leukocytoclastic vasculitis. 

A 64-year-old man with type II diabetes, hypertension, and bilateral renal artery stenosis presented with confusion and dysarthria related to profound hypoglycemia (2.2 mmol/1). He was taking naproxen 500 mg bd, ramipril 2.5 mg/day, glibenclamide 2.5 mg bd, metformin 850 mg bd, a thiazide diuretic, terazosin, ranitidine, paracetamol, and codeine. His plasma creatinine concentration, previously 185 pmol/1, was 362 pmol/1 and it fell to 210 imol/l after the withdrawal of ramipril and naproxen. 

With these difficulties in mind, drug treatment programs do surprisingly well at keeping people on the road to recovery. The NIDA says the treatment of addiction is as successful in 2002 as the treatment of other chronic diseases such as diabetes, hypertension, and asthma. 

The consequences and correlates of sleep deprivation in its various forms are extensively reviewed in a number of other chapters (e.g., Chaps. 10-19), and will not be reviewed here. Briefly, there is growing evidence that sleep deprivation and sleep disruption are associated with negative mood, decreased productivity, occupational and transportation accidents, reduced quality of life, poor school attendance, impairment of performance, learning, memory, and physiological changes that theoretically increase the risk of major illnesses, such as diabetes, hypertension, and obesity. 

As well as their effects on the brain, neuroleptics commonly produce other potentially lethal effects. They are all toxic to the heart, inducing conduction defects and arrhythmias. Olanzapine and clozapine also interfere with normal metabolism, causing what is known as metabolic syndrome. This syndrome has only recently been described and is defined as the occurrence of obesity, diabetes, hypertension and dyslipidaemia6 (Shirzadi Ghaemi 2006). The underlying cause of the syndrome is thought to be resistance to insulin. All these effects... 

The chance that an obese child will become an obese adult is estimated to increase from approximately 20% if overweight at age 4 years to approximately 80% if overweight during adolescence (Guo and Chumlea, 1999). Patients who are overweight are at a higher risk for type 2 diabetes, hypertension, and dyslipidemia. 

Up to 30% of all coronary heart disease deaths have been attributed to unhealthy diets. In 1980, 8% of women were obese and 6% of men. By 1998, however, the prevalence had almost trebled to 21% of women and 17% of men. The four most common problems linked to obesity are heart disease, type 2 diabetes, hypertension and osteoarthritis (National Audit Office, 2001). 

Epidemiological studies have identified a number of factors that contribute to the risk of developing cirrhosis. Regular (moderate) alcohol consumption, age older than 50 years, and male gender are examples that increase cirrhosis risk in chronic hepatitis C infection, and older age, obesity, insulin resistance or type 2 diabetes, hypertension and hyperlipidaemia in non-alcoholic steatohepatitis. 

Obesity is probably the oldest metabolic disturbance. People in a society become obese as soon as enough food and leisure are available to cause an imbalance between energy intake and energy expenditure. Obesity is becoming a more important risk factor for the development of diabetes, hypertension and cardiovascular disease. It has multiple causes the development of obesity is a complex interaction between genetic, psychological, socioeconomic and cultural factors. Individuals have unique genetic and environmental factors that affect how food is processed there are, therefore, individual differences in susceptibility to obesity. 

In acromegaly, excess growth hormone causes diabetes, hypertension and arthritis. The former two lead to a 2-fold excess in cardiovascular mortality. Surgery is the treatment of choice. Growth hormone secretion is reduced by octreotide and other somatostatin analogues and to a lesser degree by bromocriptine (see Index). 

Women of blood group O have less of a risk of thromboembolism (15). The risk of thromboembolic complications may be greater where there is a history of diabetes, hypertension, and pre-eclamptic toxemia. In some studies there has been an association with type II hyperlipoproteinemia, hypercholesterolemia, and atheroma (62-66). Hypertension may be an additional risk factor when considered in relation to oral contraceptive use. 

Thais S-W, Korrick S, Schwartz J, Amasiriwardena C, Aro A, Sparrow D, Hu H. Lead diabetes, hypertension, and renai function Normative Aging Study. Environ Heaith Perspect 2004 112 1178-1182. 

Reaven (1988) suggested that insulin resistance might be a common denominator for obesity, Type-II diabetes hypertension and hyperlipidaemia (metabolic syndrome) and should be treated rigorously to avoid coronary heart disease, the most common cause of morbidity and mortality in Type-II diabetes mellitus. However, it still remains to be proven that effective blood glucose control will reduce the mortality of the disease (Turner and Holman, 1990). 

Sjostrom, C. D., L. Lissner, H. Wedel and L. Sjostrom (1999). Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery the SOS Intervention Study. Obes Res 7(5) 477-84. 

Most beneficiaries use drugs. The distribution of the use of drugs is slanted toward patients with chronic conditions of diabetes, hypertension, and cardiovascular diseases. Adverse patient selection to participate is an important issue, because there is an uneven distribution of drug use, and patients must utilize medications over a long period of time. 

The complexity of the heart failure syndrome necessitates a comprehensive approach to management that includes accurate diagnosis, identification and treatment of risk factors (e.g., diabetes, hypertension, and coronary artery disease), elimination or minimization of precipitating factors such as NSAlDs, and appropriate pharmacologic and nonpharmacologic therapy. 

Many women with pregnancy-inflnenced gastrointestinal issues can be treated safely with lifestyle modification or medications, many of them nonprescription. Gestational diabetes, hypertension, and thyrotoxicosis may or may not require drug therapy venous thromboembolism usually will require therapy with a low-molecular-weight heparin and compression stockings. 

Some herbal and food supplement diet agents contain sources of pharmacologically active substances that should be used with caution or avoided in obese patients with conditions such as diabetes, hypertension, and significant cardiovascular disease. 

There is extensive evidence that accumulation and subsequent oxidative modification of LDL particles in the subendothelial space play a key role in development and progression of atherosclerosis (Lusis 2000 Berliner et al. 1995 Leitinger 2005). Phospholipid oxidation products are found at high concentrations within fatty streak lesions of cholesterol fed rabbits, mice, and in human atherosclerotic lesions (Watson et al. 1997 Berliner et al. 2001 Subbanagounder et al. 2000 Subbanagounder et al. 2000 Huber et al. 2002). Antibodies against OxPL are present in the serum of apoE-deficient mice and the presence of antibodies against OxPL in patients with atherosclerosis, diabetes, hypertension and other chronic inflammatory diseases further underlines the importance and potential functional relevance of these molecules (Binder et al. 2005). 

It is a local anaesthetic of the amide type which is employed for surface, infiltration and nerve block anaesthesia. Its duration of action is in between the shorter-acting lidocaine and longer-acting mepivacaine. It possesses less vaso-dilator activity than lidocaine and hence may be used without adrenaline. Therefore, solutions of prilocaine hydrochloride are specifically beneficial for such patients who cannot tolerate vasopressor agents patients having cardiovascular disorders, diabetes, hypertension and thyrotoxicosis. 

---